Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $356,111 - $661,900
-2,816 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$225.82 - $368.51 $635,909 - $1.04 Million
2,816 New
2,816 $715,000
Q3 2021

Nov 10, 2021

SELL
$221.9 - $484.47 $803,499 - $1.75 Million
-3,621 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $66,384 - $120,074
-511 Reduced 12.37%
3,621 $851,000
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $413,027 - $703,562
-3,783 Reduced 47.8%
4,132 $541,000
Q4 2020

Feb 08, 2021

SELL
$65.74 - $169.86 $774,351 - $2 Million
-11,779 Reduced 59.81%
7,915 $827,000
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $89,497 - $156,217
-1,647 Reduced 7.72%
19,694 $1.39 Million
Q2 2020

Aug 11, 2020

BUY
$29.67 - $80.0 $633,187 - $1.71 Million
21,341 New
21,341 $1.37 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.